Pacritinib and Ibutilide: Interaction Details

Brand names
Pacritinib
Vonjo
Ibutilide
Corvert
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Ibutilide

Brand name
  • Corvert

We don't have a drug information page for Ibutilide yet. Have a question about Ibutilide? Ask a pharmacist, free →

What Happens When You Take Pacritinib With Ibutilide

What can happen when they are taken together (rated Major)

An increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Pacritinib should not be given together with any drug known to prolong the . Using other QT-prolonging drugs at the same time may add to the QTc-prolonging effect of pacritinib and raise the risk of cardiac .

Patients whose baseline QTc exceeds 480 msec should not receive pacritinib. Pacritinib should be held if the lengthens beyond 500 msec or rises by more than 60 msec from baseline.

When QTc prolongation returns to 480 msec or less, or to baseline, within 1 week, pacritinib can be resumed at the same dose. If resolution takes longer than 1 week, pacritinib should be resumed at a reduced dose. When the combination cannot be avoided, should be corrected before and throughout pacritinib therapy, and QTc prolongation should be managed by interrupting pacritinib and managing electrolytes.1

The Pacritinib and Ibutilide Interaction, Explained

Both of these medicines can affect your heart's electrical rhythm. Pacritinib (Vonjo) is used for a bone marrow condition called myelofibrosis. Ibutilide (Corvert) is given to restore a normal rhythm in atrial fibrillation or flutter. Each can lengthen the "," a part of the heartbeat cycle. Together, the effect may add up and raise the chance of a dangerous irregular heartbeat. This concern is based on how the drugs are expected to act, not on large studies in people.

Please don't change anything on your own. Tell your pharmacist or doctor about both medicines. Your care team can check your heart tracing () and potassium levels and decide the safest plan for you.

() between pacritinib and ibutilide, a class III antiarrhythmic with a known risk of . Evidence is theoretical; onset is unspecified. Severity is rated major. Neither drug's effect depends on the other's ; the concern is additive risk.

  • Avoid where possible. Avoid pacritinib if baseline is above 480 msec.
  • Correct before and during therapy, and manage electrolytes.
  • If QTc exceeds 500 msec or rises more than 60 msec from baseline, hold pacritinib.
  • If QTc returns to 480 msec or less (or baseline) within 1 week, restart at the same dose. If resolution takes longer than 1 week, restart at a reduced dose.
  • Monitor when use is unavoidable.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Pacritinib and Ibutilide Interact

The likely mechanism


In short: Pacritinib and ibutilide both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Pacritinib and Ibutilide Interaction

Your care team usually tries to avoid using these two together. If both are truly needed, they may take extra precautions.

  • Keep taking your medicines as prescribed unless your prescriber tells you otherwise, and tell them about every medicine you take.
  • Your team may check your heart rhythm () and make sure your potassium level is in a healthy range before and during treatment.
  • If your heart tracing shows significant QT lengthening, your doctor may pause pacritinib, then restart it at the same dose or a lower, individualized dose depending on how quickly things settle.
  • Report fainting, dizziness, or a racing or pounding heartbeat right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Pacritinib or Ibutilide need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Pacritinib and Ibutilide: Common Questions

How serious is the Pacritinib and Ibutilide interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Pacritinib and Ibutilide interaction managed?

Your care team usually tries to avoid using these two together. If both are truly needed, they may take extra precautions. Keep taking your medicines as prescribed unless your prescriber tells you otherwise, and tell them about every medicine you take. Your team may check your heart rhythm () and make sure your potassium level is in a healthy range before and during treatment. If your heart tra… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Pacritinib and Ibutilide Interaction

Ask in your own words about taking Pacritinib and Ibutilide together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Pacritinib and Ibutilide

Also serious with Pacritinib

Also serious with Ibutilide

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Pacritinib

With Ibutilide

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.